Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73) - Image 1

£166.32

Springer Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)

Name: Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)
Brand: Springer
Price: 166.32 GBP
Availability: InStock

Oncology

This is the most expensive it has ever been. Walk away.

£166 today · previous high £166 · all-time low £166

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 65 days · 65 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 65 days • 1 price levels

Days at Price

Price Analysis

Most common price: £166 (65 days, 100.0%)

Price range: £166 - £166

Price levels: 1 different prices over 65 days

Description

Over the last 50 years, drug development and clinical trials have resulted in successful complete responses in diseases such as childhood leukemia, testicular cancer and Hodgkin's disease. We are still, however, confronted with over 500,000 cancer-related deaths per year. Clearly, the phenomenon of drug resistance is largely responsible for these failures and continues to be an area of active investigation. Since the last volume in this series, we have learned that the energy-dependent drug efflux protein, p-glycoprotein, encoded by the MDR 1 gene, is a member of a family of structurally related transport polypeptides, thus allowing us to explore the relationship between structure and function. In addition to ongoing well designed clinical trials aimed at reversing MDR mediated drug resistance, the first gene therapy studies with the MDR 1 gene retrovirally transduced into human bone marrow cells are about to be initiated. Although MDR is currently the most understood mechanism of drug resistance, we are uncovering increasing knowledge of alternative molecular and biochemical mechanisms of drug resistance to antimetabolites, cisplatin and alkylating agents and developing new strategies for circumventing such resistance. It is clear that drug resistance is complex, and many mechanisms exist by which cancer cells may overcome the cytotoxicity of our known chemotherapeutic agents. As our understanding of each of these mechanisms expands, well designed models will be necessary to test laboratory hypotheses and determine their relationship to drug resistance in humans. It is this integration of basic science and clinical investigation that will both advance our scientific knowledge and result in the improvement of cancer therapy.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0792328361
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 31 December 1994
Listed Since: 15 December 2006

Barcode

No barcode data available

Springer Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Cancer Drug Resistance Research Perspectives

Molecular and Cellular Biology of Multidrug Resistance in Tumour Cells

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance: 1 (Resistance to Targeted Anti-Cancer Therapeutics, 1)

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Pharmaceutical Perspectives of Cancer Therapeutics

Molecular Targeted Therapy of Lung Cancer

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Cancer Drug Discovery: Science and History

New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)

Gene Regulation and Therapeutics for Cancer

Drug Discovery in Pancreatic Cancer: Models and Techniques

Cancer Drug Design and Discovery